首页> 外文期刊>Internet Journal of Orthopedic Surgery >Bone grafting and internal fixation of intracapsular femoral neck fracture. Two years follow up in five patients with a novel fixation device.
【24h】

Bone grafting and internal fixation of intracapsular femoral neck fracture. Two years follow up in five patients with a novel fixation device.

机译:囊内股骨颈骨折的骨移植和内固定。使用新型固定装置对5名患者进行了两年的随访。

获取原文
           

摘要

Objectives: To test the safety and effectiveness of a novel procedure and device for fixation of displaced or non-displaced intracapsular femoral neck fractures, in order to preserve the natural femoral head and prevent the need for partial or total hip replacement. Design: Single- arm, prospective clinical investigation. Setting: Patients admitted to the Orthopedic Department. Participants: Male and female patients between the ages of 50 and 75 with a Garden I-III type intracapsular femoral fracture. Intervention: Internal fixation with the WaisFix 100i device, and bone graft with bone substitute. Measurements: Experimental and computer simulator testing prior to clinical evaluation by mechanical and numerical modeling, and clinical and radiological follow-up. Results: Five women with Garden I-III type intracapsular femoral fracture underwent internal fixation and bone graft with the WaisFix 100i device. The operations were performed 8 to 26 hours following the traumatic event. There were no peri-operative complications or infections, and bleeding was negligible. The average hospitalization following surgery was 4 days, and hospital rehabilitation time was two weeks. Clinical and radiological bone union (eight to ten weeks) and optimal alignment were achieved in all cases. No cases of avascular necrosis, mechanical device failure or indication for hip replacement were observed after >2 years. Conclusion: At >2-years follow-up, the WaisFix100i internal fixation device and bone graft for intracapsular femoral neck fractures demonstrated safety, assessed by lack of complications; and effectiveness, assessed by rigid and stable fixation and short healing time. Introduction As the average lifespan increases, so do the health and financial burdens posed by hip fractures. Even if the incidence rates remain stable, estimated worldwide incidence is expected to increase from 1.7 million annually in 1990 to 6.3 million in 2050 [1]. A rising trend in osteoporosis [2] will further boost this figure; a mere 1% increase in incidence is expected to result in 8.2 million cases annually [1]. A recent study of 7753 residents in Canada revealed that one in six women over age 50 will sustain hip fracture, and that hip fracture increases the risk of death 3.2 fold [3]. Hip fracture treatment is costly, comprising 72% of the total costs of bone fractures in the year 2005, compared with only 14% of the total incidence [4]. One-year mortality rates range from 14% to 36% [5]. Deep vein thrombosis, pulmonary embolism, pneumonia, chronic pain, restricted mobility and poor rehabilitation are consequences of hip fracture that negatively impact patients? health and quality of life. Fifty percent of hip fractures are displaced or non-displaced intracapsular fractures [6]. Intracapsular fracture is also called “the unsolved fracture” of the femoral neck. Cannulated screws, sliding hip screws and Hansson pin-hook are commonly used for internal fixation of intracapsular femoral neck fractures. Less invasive than hemiarthroplasty or hip replacement, such techniques have demonstrated relatively few perioperative and postoperative complications [7, 8] and less operative blood loss. However, mechanical failure, non-union, cut-out and avascular necrosis are drawbacks of internal fixation procedures. As a result, many orthopaedic surgeons prefer partial or total hip arthroplasty [5, 8-12]. In randomized trials, more repeat procedures were required following internal fixation (34– 43%) than hemiarthroplasty (4-6%) [13-16]. A meta-analysis of 106 published reports [17] showed that within two years of internal fixation of a displaced fracture of the femoral neck, non-union presented in 33 percent of the patients and avascular necrosis of the femoral neck in 16 percent. In a recent randomized controlled trial, functional outcome, as assessed by higher Harris Hip Scores at 4 and 12 months postoperatively, was greater for hemiarthroplasty than for internal fixation [18].
机译:目的:为了测试一种新颖的方法和装置固定移位或未移位的囊内股骨颈骨折的安全性和有效性,以保护自然的股骨头并防止需要部分或全部髋关节置换。设计:单臂,前瞻性临床研究。地点:骨科收治的患者。研究对象:年龄在50到75岁之间且患有Garden I-III型荚膜内股骨骨折的男性和女性患者。干预:使用WaisFix 100i设备进行内部固定,并使用骨替代物进行骨移植。测量:在通过机械和数值模型进行临床评估之前进行实验和计算机模拟器测试,以及临床和放射学随访。结果:五名患有Garden I-III型荚膜内股骨骨折的妇女接受了WaisFix 100i装置的内固定和植骨。创伤事件发生后8至26小时进行了手术。没有围手术期并发症或感染,出血可以忽略不计。手术后的平均住院时间为4天,医院康复时间为2周。在所有情况下均实现了临床和放射学上的骨结合(八至十周)和最佳对准。 > 2年后未观察到无血管坏死,机械设备故障或髋关节置换指征的病例。结论:在> 2年的随访中,WaisFix100i内固定装置和植骨用于股骨颈内囊骨折的手术显示安全性,且无并发症。牢固稳定的固定和较短的愈合时间来评估其有效性。引言随着人均寿命的增加,髋部骨折所造成的健康和经济负担也会增加。即使发病率保持稳定,估计全世界的发病率也将从1990年的每年170万增加到2050年的630万[1]。骨质疏松症的上升趋势[2]将进一步提高这一数字;发病率仅增加1%,预计每年将导致820万例[1]。加拿大最近对7753名居民进行的研究表明,年龄在50岁以上的女性中有六分之一会保持髋部骨折,而髋部骨折会使死亡风险增加3.2倍[3]。髋部骨折治疗费用昂贵,在2005年占骨折总费用的72%,而在总发生率中仅占14%[4]。一年死亡率范围从14%到36%[5]。深静脉血栓形成,肺栓塞,肺炎,慢性疼痛,活动受限和康复不佳是髋部骨折对患者产生负面影响的后果吗?健康和生活质量。 50%的髋部骨折是移位的或未移位的囊内骨折[6]。囊内骨折也称为股骨颈“未解决的骨折”。空心螺钉,髋关节滑动螺钉和Hansson针钩通常用于内固定股骨颈骨折。与半髋关节置换术或髋关节置换术相比,这种技术的侵入性较小,已证明围手术期和术后并发症相对较少[7,8],并且术中出血较少。然而,机械衰竭,不愈合,切开和无血管坏死是内固定程序的缺点。结果,许多整形外科医生更喜欢部分或全部髋关节置换术[5,8-12]。在随机试验中,内固定术后(34-43%)比半髋置换术(4-6%)需要更多的重复手术[13-16]。对106篇已发表的报道进行的荟萃分析[17]显示,在对股骨颈移位性骨折进行内固定的两年内,33%的患者出现骨不连,16%的股骨颈发生血管坏死。在最近的一项随机对照试验中,根据术后4和12个月的较高Harris髋关节评分评估的功能结果,半髋置换术比内固定术[18]更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号